- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Chronic Hepatitis C, Genotype 1 in New Zealand
Total 665 results
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
GlobeImmuneCompleted
-
AbbVie (prior sponsor, Abbott)CompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV)United States, Australia, Canada, France, Germany, New Zealand, Puerto Rico, Spain, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedHepatitis C | Chronic Hepatitis C Infection | HCV | Hepatitis C Genotype 1United States, Puerto Rico
-
HanAll BioPharma Co., Ltd.CompletedChronic Hepatitis C Infection | Genotype 1United States
-
Janssen Infectious Diseases BVBAVertex Pharmaceuticals IncorporatedCompletedGenotype 1 Chronic Hepatitis C | Treatment NaiveUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Spain, Sweden, Brazil, Austria, Ireland, Mexico
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1United States
-
Bristol-Myers SquibbWithdrawnChronic Hepatitis C Virus Genotype 1United States
-
Novartis PharmaceuticalsCompletedChronic Hepatitis C Genotype-1 RelapseBelgium, United States, Germany, Spain, Puerto Rico, Taiwan, Australia
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Hoffmann-La RocheCompletedHepatitis C, Chronic, Healthy VolunteerNew Zealand
-
Gilead SciencesCompleted
-
Antipodean Pharmaceuticals, Inc.Completed
-
AbbVieCompletedChronic Hepatitis C Virus (HCV) Infection Genotype 1Algeria, Australia, Belgium, Bulgaria, Canada, Denmark, Finland, France, Germany, Greece, Israel, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Switzerland, Turkey, Austria, Ireland and more
-
Chronic Liver Disease FoundationMerck Sharp & Dohme LLC; SCRI Development Innovations, LLCCompletedChronic Hepatitis C | Genotype 1United States
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Alios Biopharma Inc.CompletedChronic Hepatitis CNew Zealand, Moldova, Republic of, Mauritius, United Kingdom
-
Bristol-Myers SquibbCompletedHepatitis C, Genotype 1United States, Australia, France, Germany, Spain, Canada, Puerto Rico, Argentina, Brazil, Russian Federation, United Kingdom, Italy, Belgium
-
Janssen R&D IrelandCompletedHepatitis C Virus Genotype-1United States, France, United Kingdom, Germany, Spain, Portugal, Canada, Puerto Rico
-
Gilead SciencesCompletedPost Liver Transplant | Recurrent Chronic Hepatitis C VirusUnited States, Spain, New Zealand, France, Germany
-
Alios Biopharma Inc.Vertex Pharmaceuticals IncorporatedTerminatedHepatitis C, ChronicAustralia, New Zealand
-
Vertex Pharmaceuticals IncorporatedTerminatedChronic Hepatitis C Virus InfectionUnited States, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis C VirusUnited States, Puerto Rico
-
Gilead SciencesCompletedHepatitis C Virus InfectionNew Zealand
-
Presidio Pharmaceuticals, Inc.CompletedHepatitis C, ChronicUnited States, Australia, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicUnited States, Canada, Slovakia, Poland, New Zealand, France, Australia
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
AbbVieCompletedHepatitis C Virus (HCV)United States, Australia, Belgium, Canada, France, New Zealand, Singapore, South Africa, Vietnam
-
Kirby InstituteMerck Sharp & Dohme LLC; The University of New South WalesCompletedChronic Hepatitis C InfectionAustralia
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompletedHepatitis C Virus InfectionUnited States, Puerto Rico
-
AbbVie (prior sponsor, Abbott)CompletedHepatitis C | Hepatitis C Virus | Chronic Hepatitis C InfectionUnited States
-
Gilead SciencesTerminatedChronic Hepatitis CUnited States, Australia, Canada, New Zealand
-
Gilead SciencesCompletedChronic Hepatitis CUnited States, Canada, New Zealand, Puerto Rico
-
Gilead SciencesCompletedChronic Hepatitis CUnited States, Canada, New Zealand, Puerto Rico, Australia
-
Hoffmann-La RocheCompletedHepatitis C, ChronicFrance, Germany, United States, New Zealand
-
AbbVie (prior sponsor, Abbott)CompletedChronic Hepatitis C InfectionUnited States
-
Gilead SciencesCompletedHepatitis CUnited States, Puerto Rico
-
Gilead SciencesCompletedChronic Hepatitis CIsrael, United Kingdom, Australia, Spain, Canada, New Zealand
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Beth Israel Medical CenterTerminatedFatty Liver | Chronic Hepatitis C InfectionUnited States
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Hepatitis Resource NetworkHoffmann-La RocheUnknownHIV Infections | Chronic Hepatitis C Infection in HIV Infected PersonsUnited States
-
Gilead SciencesTerminatedHepatitis C Virus InfectionUnited States, United Kingdom, Australia, Germany, Italy, New Zealand, Belgium, Poland, Russian Federation
-
Gilead SciencesCompleted
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand